Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "osteoporosis"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
9
of
9
Search:
'"osteoporosis"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Denosumab (Prolia) : treatment to increase bone mass in men with osteoporosis at high risk for fracture, or who have failed or are intolerant to other available osteoporosis therap...
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Osteoporosis
/ drug therapy...
”
Read Now
2
Denosumab (Prolia) : treatment to increase bone mass in men with osteoporosis at high risk for fracture, or who have failed or are intolerant to other available osteoporosis therap...
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Osteoporosis
is a skeletal disorder characterized by compromised bone strength predisposing...
”
Read Now
3
Denosumab versus zoledronic acid for men with
osteoporosis
: a review of clinical effectiveness and guidelines
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Osteoporosis
/ drug therapy...
”
Read Now
4
Denosumab versus zoledronic acid for adults with
osteoporosis
: a review of cost-effectiveness
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Osteoporosis
/ drug therapy...
”
Read Now
5
Denosumab versus zoledronic acid for adults with
osteoporosis
: a review of cost-effectiveness
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... for the treatment of postmenopausal women and men with
osteoporosis
, including women receiving adjuvant aromatase...
”
Read Now
6
Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal
osteoporosis
: clinical effectiveness and harms
by
Gauthier, Kasandra
Published 2012
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Osteoporosis
, Postmenopausal / drug therapy...
”
Read Now
7
Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal
osteoporosis
: clinical effectiveness and harms
by
Gauthier, Kasandra
Published 2012
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Osteoporosis
, Postmenopausal / drug therapy...
”
Read Now
8
Vitamin D testing in the general population : a review of the clinical and cost-effectiveness and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
....,
osteoporosis
, rickets, osteomalacia, malabsorption syndromes, renal disease, and individuals taking medications...
”
Read Now
9
Vitamin D testing in the general population : a review of the clinical and cost-effectiveness and guidelines
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
....,
osteoporosis
, rickets, osteomalacia, malabsorption syndromes, renal disease, and individuals taking medications...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
5
330 - Economics
4
Language
English
9
Collection
National Center for Biotechnology Information
9
Author
Canadian Agency for Drugs and Technologies in Health
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
2
Gauthier, Kasandra
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22osteoporosis%22&type=AllFields
Send by Email
×
Loading...